- Early access strategy development
Building Stronger Market Access Pathways for Medical Technology Companies
We help medical device manufacturers navigate payer expectations, reimbursement frameworks, and procurement systems with clear, implementation-focused strategy.
We help medical device manufacturers navigate payer expectations, reimbursement frameworks, and procurement systems with clear, implementation-focused strategy.
Medical Device Market Access Services
Bringing a medical device to market requires more than regulatory clearance. Commercial success depends on pricing structure, reimbursement positioning, evidence strategy, and the ability to demonstrate measurable value to payers and procurement bodies. At WH Partners, our medical device market access services are designed to help manufacturers navigate complex healthcare systems with clarity and strategic focus.
We work with medical technology companies that require structured, practical guidance across the full market access journey. From early strategic planning to launch preparation and post-launch optimization, our approach emphasizes measurable outcomes, sustainable pricing, and long-term access stability. We provide Pricing and Reimbursement strategic advice to ensure your device achieves both regulatory and commercial success.
Strategic Medical Device Market Access Services for Sustainable Growth
Market access for medical devices in Switzerland and the EU requires compliance with the European Medical Device Regulation (EU MDR) or IVDR. Switzerland generally mirrors EU regulations and unilaterally accepts CE-marked devices, but operates as a legally independent “third country” without mutual.
Our team supports:
Your Medical Device Reimbursement Support for Swiss and European Markets
Selecting the right medical device reimbursement Consultant can significantly influence adoption speed and revenue realization. WH Partners combines strategic insight with hands on execution support. We focus on practical pathways that reflect real world hospital procurement processes, payer decision frameworks, and health technology assessment dynamics.
Market Landscape Assessment
We evaluate competitive positioning, pricing benchmarks, reimbursement precedents, and policy trends, ensuring your strategy is grounded in real-world data rather than assumptions.
Value and Evidence Strategy
Payers expect clear economic justification. We help translate clinical outcomes into compelling economic value narratives that resonate with reimbursement authorities and BAG Spezialitätenliste requirements.
Pricing Strategy Development
Pricing must balance competitiveness, sustainability, and cross-market impact. We support reference pricing analysis, scenario modeling, and risk assessment to minimize downstream challenges, leveraging our Pharma Pricing and Reimbursement consultant expertise.
Reimbursement Dossier Preparation
Submission of documents requires precision and consistency. We help structure and refine dossiers to ensure they clearly communicate clinical and economic value.
Why Choose Us?
Choosing the right partner for medical technology market access is a strategic decision. WH Partners combines healthcare system expertise with practical implementation support, providing dedicated Pricing and Reimbursement consulting services across Swiss and European markets.
Specialized Expertise
We focus on healthcare and life sciences strategy, including complex device reimbursement environments. Our experience across Swiss and European systems allows us to provide realistic, actionable insight.
Senior Level Involvement
You work directly with experienced consultants who understand the nuances of Swiss and European healthcare systems. We stay actively involved throughout the engagement, ensuring consistency and quality.
Our recommendations are designed for implementation. We translate regulatory, economic, and clinical considerations into clear action steps your teams can execute effectively.
Tailored Solutions
Each device category and market context is different. We design customized strategies aligned with your timelines, internal capabilities, and commercial priorities.
Collaborative Approach
We work closely with cross functional teams to ensure alignment between regulatory, medical, commercial, and health economics functions. Clear communication and shared understanding drive stronger outcomes.
Long Term Perspective
Market access evolves with policy, innovation, and competitive pressure. We help build resilient strategies designed to sustain adoption and reimbursement over time.
While we have strong expertise in Switzerland, we also support broader European market access strategies.
You can contact us to schedule an initial consultation. We will discuss your objectives, timelines, and challenges before defining a tailored engagement plan.
A Structured Yet Flexible Consulting Model
As a specialized advisory firm in medical technology strategy, we recognize that every device, indication, and company structure presents unique challenges. Our methodology combines a clear analytical framework with flexibility to adapt across therapeutic areas, device classes, and organizational maturity levels.
We begin with a focused discovery session to understand your product profile, evidence base, target markets, and commercial objectives. These insights are translated into a practical roadmap with defined milestones, timelines, and responsibilities. Throughout the engagement, we collaborate closely with regulatory, clinical, commercial, and health economics teams to ensure alignment and transparent communication at every stage.
We prioritize:
A Long-Term Partnership Approach
Our support extends beyond individual submissions or launch projects. Many clients engage us as ongoing advisors throughout product development and commercialization. This continuity allows us to refine strategy as new data emerges and reimbursement landscapes evolve.
Through disciplined analysis and collaborative execution, we help transform complex access challenges into structured, manageable pathways for growth.
If you are preparing for market entry, expanding into Switzerland, or reassessing pricing and reimbursement strategy for an existing device portfolio, WH Partners provides experienced guidance tailored to your objectives.
Frequently Asked Questions
What makes medical device market access different from pharmaceuticals?
Medical devices often involve hospital procurement systems, DRG frameworks, and coding considerations in addition to reimbursement evaluation. This creates a distinct access pathway requiring a tailored strategy.
When should device manufacturers begin market access planning?
Ideally during early product development to ensure clinical and economic evidence generation aligns with payer and hospital expectations.
How does Swiss market access differ from other European markets?
Swiss pharma market access diverges from the EU through its total independence from the European Medicines Agency (EMA), a centralized pricing & reimbursement control by the BAG for the outpatient population, a mandatory health technology assessment (HTA), and a pricing system based on WZW (Efficacy, Suitability, Economics) that result in slower access to innovative medicines than in countries like Germany and UK.
What evidence supports medical device reimbursement approval?
Reimbursement typically requires clinical effectiveness data, safety outcomes, and economic justification such as cost impact or cost effectiveness analysis, depending on the market and device type.
What is included in a Pricing Strategy
A pricing strategy for pharmaceutical therapies seeks the balance between drug therapie’s:
- Medical/Scientific sustainability
- Financial soundness
- Political acceptance
- Social accessibility
Can you assist with reimbursement dossiers preparation ?
Yes, particularly in Switzerland we develop assist and develop the pricing and reimbursement dossier according to BAG SL requirements. In other countries we provide strategic dossier development assistance and support local development through our local partners.
Do you only focus on Switzerland?
While we have strong expertise in Switzerland, we also support broader European and Latin America market access strategies.
How do we begin working with WH Partners?
You can contact us to schedule an initial consultation. We will discuss your objectives, timelines, and market priorities before defining a tailored engagement roadmap.